A double-blind randomized study comparing the effects of continuing or not continuing rosiglitazone + metformin therapy when starting insulin therapy in people with Type 2 diabetes1

AIMS: To compare the efficacy and safety of either continuing or discontinuing rosiglitazone + metformin fixed-dose combination when starting insulin therapy in people with Type 2 diabetes inadequately controlled on oral therapy. METHODS: In this 24-week double-blind study, 324 individuals with Type...

Descripción completa

Detalles Bibliográficos
Autores principales: Home, P D, Bailey, C J, Donaldson, J, Chen, H, Stewart, M W
Formato: Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2007
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1974817/
https://www.ncbi.nlm.nih.gov/pubmed/17403121
http://dx.doi.org/10.1111/j.1464-5491.2007.02141.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1974817/
https://www.ncbi.nlm.nih.gov/pubmed/17403121
http://dx.doi.org/10.1111/j.1464-5491.2007.02141.x

Ejemplares similares